Thyroid Mutations and Implications for Clinical Treatment
This article provides an overview of the evolving paradigm in the management of aggressive thyroid cancer. While differentiated thyroid cancer (DTC) generally has a favorable prognosis, subsets such as radioactive iodine-refractory DTC, medullary thyroid cancer, and anaplastic thyroid cancer present...
Saved in:
Main Authors: | Emily S. Zhang, Joseph Scharpf |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2024-12-01
|
Series: | Journal of Head & Neck Physicians and Surgeons |
Subjects: | |
Online Access: | https://journals.lww.com/10.4103/jhnps.jhnps_122_24 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
TERT promoter mutations in thyroid cancer
by: Michiko Matsuse, et al.
Published: (2023-11-01) -
Distinct Impacts of Clinicopathological and Mutational Profiles on Long-Term Survival and Recurrence in Medullary Thyroid Carcinoma
by: Moon Young Oh, et al.
Published: (2024-12-01) -
Poorly differentiated thyroid cancer: Clinical, pathological, mutational, and outcome analysis
by: Amit Agarwal, et al.
Published: (2024-12-01) -
Thermal ablation for the treatment of malignant thyroid nodules: present and future
by: Yan Hu, et al.
Published: (2024-12-01) -
BRAF V600E-mutated lung adenocarcinoma with thyroid metastasis as the initial manifestation: a case report
by: Yufei Liu, et al.
Published: (2025-02-01)